Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

ACCELERON PHARMA INC (XLRN) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $121.19 Metrics
OS: 61.2 M -35 % ROE
Market cap: $7.41 B -61 % ROIC
Net cash: $653 M $10.67 per share
EV: $6.76 B

 
TTM Valuation
EBITDA ($248) M
EBIT ($252) M
EPS ($4.26)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
Revenues92.574.014.013.527.818.114.657.2
            Revenue growth25.0%428.9%3.8%-51.5%53.5%23.7%-74.4%275.2%
Cost of goods sold0.00.00.00.00.00.05.00.0
Gross profit92.574.014.013.527.818.19.657.2
            Gross margin100.0%100.0%100.0%100.0%100.0%100.0%65.8%100.0%
Selling, general and administrative85.956.534.533.7    
Research and development173.9154.0103.989.768.658.450.936.1
General and administrative    25.320.614.214.2
EBIT-165.4-136.1-124.4-110.0-73.4-57.4-60.57.0
            EBIT margin-178.8%-183.9%-889.2%-815.8%-264.3%-317.1%-413.2%12.1%
Pre-tax income-166.0-124.9-118.9-108.4-57.0-63.9-51.3-21.9
Income taxes0.0-0.10.00.00.00.00.00.0
            Tax rate 0.0%0.0%  0.0%0.0%0.0%
Net income-166.0-124.9-118.9-108.5-57.0-63.9-51.3-39.0
            Net margin-179.4%-168.7%-849.6%-804.5%-205.3%-353.1%-350.3%-68.2%
 
Diluted EPS($2.92)($2.38)($2.59)($2.68)($1.52)($1.92)($1.63)($4.15)
Shares outstanding (diluted)56.852.545.940.437.433.331.59.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy